{"id":"https://openalex.org/W2019787647","doi":"https://doi.org/10.1097/00004850-200311000-00002","title":"A score for predicting response to pharmacotherapy in obsessive???compulsive disorder","display_name":"A score for predicting response to pharmacotherapy in obsessive???compulsive disorder","publication_year":2003,"publication_date":"2003-11-01","ids":{"openalex":"https://openalex.org/W2019787647","doi":"https://doi.org/10.1097/00004850-200311000-00002","mag":"2019787647","pmid":"https://pubmed.ncbi.nlm.nih.gov/14571151"},"language":"en","primary_location":{"id":"doi:10.1097/00004850-200311000-00002","doi":"https://doi.org/10.1097/00004850-200311000-00002","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-200311000-00002","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010458603","display_name":"Damiaan A J P Denys","orcid":"https://orcid.org/0000-0002-3191-3844","observed_orcids":["https://orcid.org/0000-0002-3191-3844"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Damiaan Denys","raw_affiliation_strings":["Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center Utrecht, The Netherlands. d.a.j.p.denys@azu.nl","Rudolf Magnus Institute of Neuroscience, Department of Psychiatry","requests for reprints to Damiaan Denys, University Medical Center, HP B.01.206, PO Box 85500, 3508 GA Utrecht, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center Utrecht, The Netherlands. d.a.j.p.denys@azu.nl","institution_ids":["https://openalex.org/I3018483916"]},{"raw_affiliation_string":"Rudolf Magnus Institute of Neuroscience, Department of Psychiatry","institution_ids":[]},{"raw_affiliation_string":"requests for reprints to Damiaan Denys, University Medical Center, HP B.01.206, PO Box 85500, 3508 GA Utrecht, The Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058280049","display_name":"Huibert Burger","orcid":"https://orcid.org/0000-0001-6484-0349","observed_orcids":["https://orcid.org/0000-0001-6484-0349"]},"institutions":[{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Huibert Burger","raw_affiliation_strings":["Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014299703","display_name":"Harold J.G.M. van Megen","orcid":"https://orcid.org/0000-0001-7532-2205","observed_orcids":["https://orcid.org/0000-0001-7532-2205"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Harold van Megen","raw_affiliation_strings":["Rudolf Magnus Institute of Neuroscience, Department of Psychiatry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rudolf Magnus Institute of Neuroscience, Department of Psychiatry","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091190491","display_name":"Femke de Geus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Femke de Geus","raw_affiliation_strings":["Rudolf Magnus Institute of Neuroscience, Department of Psychiatry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rudolf Magnus Institute of Neuroscience, Department of Psychiatry","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109168890","display_name":"Herman G.M. Westenberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Herman Westenberg","raw_affiliation_strings":["Rudolf Magnus Institute of Neuroscience, Department of Psychiatry"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rudolf Magnus Institute of Neuroscience, Department of Psychiatry","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5010458603"],"corresponding_institution_ids":["https://openalex.org/I3018483916"],"apc_list":null,"apc_paid":null,"fwci":4.8939,"has_fulltext":false,"cited_by_count":68,"citation_normalized_percentile":{"value":0.94125413,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"18","issue":"6","first_page":"315","last_page":"322"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":1.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11132","display_name":"Psychoanalysis and Psychopathology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/obsessive-compulsive-disorder","display_name":"obsessive-compulsive disorder","score":1.0},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.8999999761581421},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7770000100135803},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":0.75},{"id":"https://openalex.org/keywords/venlafaxine","display_name":"venlafaxine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/serotonin-norepinephrine-reuptake-inhibitors","display_name":"serotonin-norepinephrine reuptake inhibitors","score":0.9649999737739563},{"id":"https://openalex.org/keywords/y-bocs","display_name":"Yale-Brown Obsessive Compulsive Scale","score":0.8370000123977661},{"id":"https://openalex.org/keywords/baseline-symptom-severity","display_name":"baseline symptom severity","score":0.7229999899864197},{"id":"https://openalex.org/keywords/depression-severity","display_name":"depression severity","score":0.6800000071525574},{"id":"https://openalex.org/keywords/predictive-model","display_name":"prediction model","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C2777828372","wikidata":"https://www.wikidata.org/wiki/Q408471","display_name":"Paroxetine","level":4,"score":0.7585350275039673},{"id":"https://openalex.org/C58471807","wikidata":"https://www.wikidata.org/wiki/Q327120","display_name":"Receiver operating characteristic","level":2,"score":0.612030029296875},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5666438937187195},{"id":"https://openalex.org/C2776466888","wikidata":"https://www.wikidata.org/wiki/Q898407","display_name":"Venlafaxine","level":4,"score":0.5466495156288147},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.5426924228668213},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5391201972961426},{"id":"https://openalex.org/C31487548","wikidata":"https://www.wikidata.org/wiki/Q4859664","display_name":"Reuptake inhibitor","level":4,"score":0.527900755405426},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.472368061542511},{"id":"https://openalex.org/C83849319","wikidata":"https://www.wikidata.org/wiki/Q7295720","display_name":"Rating scale","level":2,"score":0.46602723002433777},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4510077238082886},{"id":"https://openalex.org/C2780092697","wikidata":"https://www.wikidata.org/wiki/Q7455053","display_name":"Serotonin reuptake inhibitor","level":4,"score":0.44812318682670593},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.4373515248298645},{"id":"https://openalex.org/C30036603","wikidata":"https://www.wikidata.org/wiki/Q17125150","display_name":"Severity of illness","level":2,"score":0.4355415999889374},{"id":"https://openalex.org/C2776466505","wikidata":"https://www.wikidata.org/wiki/Q385555","display_name":"Hamilton Rating Scale for Depression","level":4,"score":0.4331788420677185},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.4297095537185669},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.40083983540534973},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.38533490896224976},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.12770730257034302},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.10294723510742188},{"id":"https://openalex.org/C138496976","wikidata":"https://www.wikidata.org/wiki/Q175002","display_name":"Developmental psychology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069470","descriptor_name":"Venlafaxine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003511","descriptor_name":"Cyclohexanols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005163","descriptor_name":"Factor Analysis, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017374","descriptor_name":"Paroxetine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018687","descriptor_name":"Antidepressive Agents, Second-Generation","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":6,"locations":[{"id":"doi:10.1097/00004850-200311000-00002","doi":"https://doi.org/10.1097/00004850-200311000-00002","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00004850-200311000-00002","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"doi:10.1097/01.yic.0000097036.25861.96","doi":"https://doi.org/10.1097/01.yic.0000097036.25861.96","is_oa":false,"landing_page_url":"https://doi.org/10.1097/01.yic.0000097036.25861.96","pdf_url":null,"source":{"id":"https://openalex.org/S149156103","display_name":"International Clinical Psychopharmacology","issn_l":"0268-1315","issn":["0268-1315","1473-5857"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International Clinical Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:14571151","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14571151","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International clinical psychopharmacology","raw_type":"Clinical Trial"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/76af3b78-beaf-495a-a974-292a0890c602","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/76af3b78-beaf-495a-a974-292a0890c602","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Denys, D, Burger, H, van Megen, H, de Geus, F & Westenberg, H 2003, 'A score for predicting response to pharmacotherapy in obsessive-compulsive disorder', International clinical psychopharmacology, vol. 18, no. 6, pp. 315-322. https://doi.org/10.1097/00004850-200311000-00002","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/afa25469-f98a-47cb-b24f-a589971fe3f6","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/a-score-for-predicting-response-to-pharmacotherapy-in-obsessivecompulsive-disorder(afa25469-f98a-47cb-b24f-a589971fe3f6).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International clinical psychopharmacology, 18(6), 315 - 322. Lippincott Williams and Wilkins","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/7af3215f-8479-41a5-ae03-bdd6e5685b9b","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/7af3215f-8479-41a5-ae03-bdd6e5685b9b","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Denys , D , Burger , H , Van Megen , H , De Geus , F &amp; Westenberg , H 2003 , ' A score for predicting response to pharmacotherapy in obsessive-compulsive disorder ' , INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , vol. 18 , no. 6 , pp. 315-322 . https://doi.org/10.1097/00004850-200311000-00002","raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"display_name":"Reduced inequalities","id":"https://metadata.un.org/sdg/10","score":0.6499999761581421}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1971573210","https://openalex.org/W1971740310","https://openalex.org/W1972715951","https://openalex.org/W1978661788","https://openalex.org/W1980290422","https://openalex.org/W1983110671","https://openalex.org/W1990454293","https://openalex.org/W1994837175","https://openalex.org/W2001138924","https://openalex.org/W2002667488","https://openalex.org/W2006867534","https://openalex.org/W2007171103","https://openalex.org/W2033472966","https://openalex.org/W2039432189","https://openalex.org/W2050252906","https://openalex.org/W2055615204","https://openalex.org/W2062931826","https://openalex.org/W2068293443","https://openalex.org/W2071780873","https://openalex.org/W2075937340","https://openalex.org/W2080172914","https://openalex.org/W2086894297","https://openalex.org/W2097231409","https://openalex.org/W2099688748","https://openalex.org/W2138447996","https://openalex.org/W2157825442","https://openalex.org/W2160070901","https://openalex.org/W2162032203","https://openalex.org/W2169546867","https://openalex.org/W2192410570","https://openalex.org/W2315899014","https://openalex.org/W2324604289","https://openalex.org/W2334177155","https://openalex.org/W4285139808","https://openalex.org/W4299396253","https://openalex.org/W4321428229"],"related_works":["https://openalex.org/W170843568","https://openalex.org/W2334177155","https://openalex.org/W2045320427","https://openalex.org/W2885340087","https://openalex.org/W2413519724","https://openalex.org/W2616158868","https://openalex.org/W2050452309","https://openalex.org/W4404407157","https://openalex.org/W2937550919","https://openalex.org/W1968640666"],"abstract_inverted_index":{"Although":[0],"there":[1],"have":[2,21],"been":[3],"many":[4],"attempts":[5],"to":[6,12,36,45,51,54,66,104,123,151,158,167,203,221],"find":[7],"predictors":[8,39],"of":[9,15,27,30,40,128,134,155,163,213,218],"therapeutic":[10],"response":[11,53,103,157,220],"antidepressant":[13],"treatment":[14,105,219],"obsessive-compulsive":[16,98,135],"disorder":[17],"(OCD),":[18],"few":[19],"reports":[20],"evaluated":[22],"the":[23,96,115,164,176,179,201,211,216],"joint":[24],"predictive":[25],"value":[26],"a":[28,73,79,86,110,194,205],"number":[29],"clinical":[31,38],"characteristics.":[32],"This":[33,198],"study":[34,199],"aimed":[35],"identify":[37,124],"outcome":[41],"in":[42,72,223],"OCD,":[43],"and":[44,59,85,102,141,171],"develop":[46],"an":[47],"easily":[48],"applicable":[49],"method":[50],"predict":[52],"drug":[55],"treatment.":[56],"One":[57],"hundred":[58],"fifty":[60],"patients":[61,224],"with":[62,78,225],"primary":[63,92],"OCD":[64],"according":[65],"DSM-IV":[67],"criteria":[68],"were":[69,149],"randomly":[70],"assigned":[71],"12-week,":[74],"double-blind,":[75],"comparison":[76],"trial":[77],"selective":[80],"serotonin":[81],"reuptake":[82,88],"inhibitor":[83,89],"(paroxetine),":[84],"serotonin-noradrenaline":[87],"(venlafaxine).":[90],"The":[91,126,160],"efficacy":[93],"parameter":[94],"was":[95,106,121,173,187],"Yale-Brown":[97],"scale":[99],"(Y-BOCS)":[100],"score,":[101],"prospectively":[107],"defined":[108],"as":[109,175],">/=":[111],"35%":[112],"decrease":[113],"from":[114],"beginning.":[116],"A":[117],"stepwise":[118],"multivariate":[119],"analysis":[120],"used":[122],"predictors.":[125],"absence":[127],"previous":[129],"therapies,":[130],"moderate":[131],"baseline":[132],"severity":[133],"symptoms":[136],"(Y-BOCS":[137],"score":[138],"<":[139],"23),":[140],"low":[142],"Hamilton":[143],"Depressive":[144],"Rating":[145],"Scale":[146],"scores":[147],"(6-15)":[148],"found":[150],"be":[152],"prognostic":[153,161],"determinants":[154],"good":[156],"pharmacotherapy.":[159],"ability":[162],"prediction":[165,214],"model":[166,206],"discriminate":[168],"between":[169],"responders":[170],"non-responders":[172],"quantified":[174],"area":[177],"under":[178],"receiver":[180],"operating/operator":[181],"characteristic":[182],"curve":[183],"(ROC":[184],"area),":[185],"which":[186],"0.71":[188],"(95%":[189],"confidence":[190],"interval":[191],"0.63-0.8),":[192],"demonstrating":[193],"reasonable":[195],"discriminatory":[196],"power.":[197],"is":[200],"first":[202],"present":[204],"that":[207],"can":[208],"estimate":[209],"by":[210],"use":[212],"rules":[215],"probability":[217],"antidepressants":[222],"OCD.":[226]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}